WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)

KOSDAQ:330350 Revenue

WITHUS PHARMACEUTICAL Co.,LTD. had revenue of 27.25B KRW in the quarter ending September 30, 2025, a decrease of -1.40%. This brings the company's revenue in the last twelve months to 102.11B, down -3.43% year-over-year. In the year 2024, WITHUS PHARMACEUTICAL Co.,LTD. had annual revenue of 102.72B with 28.21% growth.

• Revenue (ttm): 102.11B
• Revenue Growth: -3.43%
• P/S Ratio: 1.09
• Revenue / Employee: 843.86M
• Employees: 121
• Market Cap: 111.69B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	102.72B	22.60B	28.21%
Dec 31, 2023	80.12B	15.44B	23.87%
Dec 31, 2022	64.68B	7.26B	12.65%
Dec 31, 2021	57.42B	4.01B	7.51%
Dec 31, 2020	53.41B	1.01B	1.93%